Anyone who has driven the streets of any British city will know there is a scourge of white vans. In fact, not all white vans contain an little, angry man you know. Some of them are driven by girls.
Life sciences companies are always a punt, but there is a lot to be said for Verona Pharma here. This is not least because the diseases and disorders it wants to tackle are increasingly common.
It’s a while since we looked at Lloyds, but much seems to have been happening. It’s still hanging in there and investors should really be paying attention while others take the headline.
So much has gone on in the fiscal universe in 2009; the crunch, quantitative easing, economies flushed with debt on both sides of the Atlantic... and in the middle, as always, is us.
subscribe to our shows via